Company intelligence / Profile preview

AppliedVR

Los Angeles, California, United Statesappliedvr.io ↗

Ownership: Private
Employees: ~200
Development stage: Commercial

Overview

AppliedVR's flagship product RelieVRx has been validated in multiple clinical trials totaling over 1,200 patients. A recent study showed that 70% of high-impact chronic pain patients were classified as low-impact at the end of treatment, with 67% maintaining that status at 12 months post-treatment. The therapy has demonstrated clinically meaningful improvements in clinically severe and diverse adults with chronic lower back pain[6].

Therapeutic areas: PsychiatryNeurologyRheumatology
Modalities: Virtual Reality (VR) therapeuticsImmersive Therapeutics (ITx)
Industry: Digital Health Medical Devices

Drug pipeline

1 asset

RelieVRx

Commercial

Indications: Chronic lower back pain

Partnerships

CurebaseKomodo HealthHighmark (payer)

Beyond the preview

Go deeper on AppliedVR.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AppliedVR.

Explore the full profile